- Kempen
- Harris NA Concentrated Equity Class A
Harris NA Concentrated Equity Class A
Profile
This strategy mainly invests in (certificates of) shares of companies listed on North American stock exchanges with a market capitalization of at least $ 5 billion at the time of purchase. The investment policy of the strategy is aimed at putting together a portfolio based on a fundamental, bottom-up stock selection process. Harris NA Concentrated Equity focuses on realizing long-term value growth. The Fund is actively managed.
Management team
Harris Associates L.P.
Performance per 2019-07-31
Slide to see more
| Fund | |
|---|---|
| 1 month | 3.8 % |
| 3 months | 1.5 % |
| This year | 25.6 % |
| 2016 | 22.0 % |
| 2017 | 3.1 % |
| 2018 | -7.2 % |
| 1 year (on annual basis) | 6.6 % |
| 3 years (on annual basis) i | 12.5 % |
| Since inception (on annual basis) i | 9.1 % |
More information can be found on the documents page of this fund
Key figures
Slide to see more
| Total fund size | EUR 19.54 M 2019-07-31 |
| Share class size | EUR 19.54 M 2019-07-31 |
| Number of shares | 528,302 2019-07-31 |
| Net Asset Value i | EUR 35.23 2019-08-22 |
| Transaction price i | EUR 35.04 2019-08-21 |
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
More information?
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
More information?
Performance per 2019-07-31
Slide to see more
| Fund | |
|---|---|
| 1 month | 3.8 % |
| 3 months | 1.5 % |
| This year | 25.6 % |
| 2016 | 22.0 % |
| 2017 | 3.1 % |
| 2018 | -7.2 % |
| 1 year (on annual basis) | 6.6 % |
| 3 years (on annual basis) i | 12.5 % |
| Since inception (on annual basis) i | 9.1 % |
Dividends
Slide to see more
| Distributing | No |
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
More information?
Top 10 holdings (2019-07-31)
5.0 %
Alphabet Class C
4.0 %
Hilton Worldwide Holdings
3.8 %
CHARTER COMMUNICATIONS INC-A
3.7 %
American International Group
3.7 %
MOODYS CORP
3.4 %
General Motors
3.2 %
Citigroup
3.2 %
Booking Holdings
3.2 %
Charles Schwab
3.2 %
CARLISLE COS INC
Total
36.4 %
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
More information?
Ongoing charges
Slide to see more
| Expected ongoing charges i | 0.75 % - 1.05 % (estimated bandwidth) |
| Ongoing charges last financial year i | 1.12 % |
The Ongoing Charges Figure of the last financial year relates to 2018.
Other costs
Slide to see more
| Upward swing factor i | 0.15 % |
| Downward swing factor i | 0.10 % |
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
More information?
Share class details
Slide to see more
| Share class | A i |
| Investor type | Institutional & Private |
| Distributing | No |
| Benchmark i | MSCI North American Index |
| Duration hedged | No |
| Investment category | Other |
| Universum | North American shares |
| Inception date | 2015-01-29 |
| Domicile | The Netherlands |
| May be offered to all investors in | The Netherlands |
| UCITS status i | No |
| Status | Open-end i |
| Base currency | EUR |
| Share class currency | EUR |
| Administrator | BNP Paribas Securities Services S.C.A. |
| Auditor | PricewaterhouseCoopers Accountants N.V. |
| Transfer agent | Van Lanschot N.V. |
| Management company | Kempen Capital Management N.V. |
| Depositary and custodian | BNP Paribas Securities Services S.C.A. |
Tradability
Slide to see more
| Listed | no |
| Subscription/Redemption Frequency | Daily |
| ISIN i | NL0011055231 |
Harris NA Concentrated Equity will only be available for orders submitted via the Transfer Agent platform of Van Lanschot N.V. Participations will only be available for distributors who submit orders on behalf of their clients, and who have been selected by the management company.
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
More information?
Read more information about Kempen Capital Management N.V. on this site and find also more information on BNP Paribas Securities Services S.C.A.
Factsheets
Show more documents Show fewer documents
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
More information?
No data available.
Harris NA Concentrated Equity NA (the Subfund) is a subfund of VermogensParapluFonds (the "Fund"). Kempen Capital Management N.V. (KCM) is the management company of the Fund. KCM is authorised as a management company and regulated by The Netherlands Authority for the Financial Markets. The Subfund is registered under the license of KCM at The Netherlands Authority for the Financial Markets. The application of the investment policy which is under the responsibility and control of the management company, is entrusted to Harris Associates L.P. This investment firm is under the supervision of the Securities and Exchange Commission (SEC), the financial regulator in the United States.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
The information in this document provides insufficient information for an investment decision. Please read the Key Investor Document and the prospectus. These documents are available on the website of KCM (www.kempen.com/en/asset-management). The value of your investment may fluctuate. Past performance provides no guarantee for the future.
More information?
